Research topics described below are educational context, not a promise to diagnose, treat, cure, or prevent disease. Review the ingredient, suggested-use, warning, and interaction information before ordering, and ask a qualified healthcare professional if the product may not be appropriate for you.
Pre-orders are live. Your $100 USD payment creates a physical pre-order for this product and is applied to its final declared price. At $100 or less, we refund any unused amount automatically and ship when ready. Above $100, we email only for the balance.
Campaign milestone: 1,000 units for this product. Orders may continue beyond the milestone; it is a production target, not an inventory cap.
A low-dose circadian signal, presented without sleeping-pill claims. Each immediate-release tablet provides 1 mg of melatonin. Timing matters, and more is not automatically better.
At a glance
| Active ingredient | Melatonin |
|---|---|
| Strength | 1 mg per tablet |
| Format | Immediate-release tablet |
| Pack | 90 tablets |
| Pre-order payment | $100 USD, recorded on this physical product order and applied to the final declared price; automatic shipment at $100 or less; balance request only above $100 |
| Product milestone | 1,000 units; pre-orders can continue after the target is reached |
Sourcing and quality
The public specification is deliberately limited to a 1 mg immediate-release tablet. Source-origin and excipient details should be taken from the final label and verified lot documentation, not inferred from marketing language. Every production lot will be third-party tested, with its lot-level Certificate of Analysis made public. This matters because published testing has found substantial label-accuracy problems in some melatonin supplements.
What the evidence does—and does not—say
Independent evidence is strongest for carefully timed circadian uses such as jet lag and shifting a delayed sleep schedule. Evidence for chronic adult insomnia is mixed, average effects are small, and major sleep guidance does not recommend melatonin as a stand-alone chronic-insomnia treatment. Long-term safety remains insufficiently established, particularly for unsupervised use in children. This product is not presented as a treatment for insomnia or any disease.
Side effects and interactions
Possible effects include next-day drowsiness, headache, dizziness, nausea or stomach discomfort, irritability, and vivid dreams. Do not drive or operate machinery if drowsy. Ask a qualified clinician before use if you are pregnant or breastfeeding, under 18, have epilepsy, an autoimmune condition, dementia, or a bleeding disorder, or take anticoagulants, immunosuppressants, sedatives, fluvoxamine or other antidepressants, blood-pressure or diabetes medicines, or estrogen-containing medicines. Alcohol and other sedatives can increase impairment.
Safety notice: This is a dietary supplement, not a medicine. It is not intended to diagnose, treat, cure, or prevent disease and should not replace medical care, prescribed treatment, or evaluation of persistent sleep problems. Follow the final product label and consult a qualified healthcare professional when appropriate.
Read the full independent Pure City Research review of melatonin →
